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A significant incidence of haemorrhage as a complication of anticoagulant therapy has previously been reported, underlining the potential danger of this fonm of treatment. Fuller (1959) reported 194 (1964) reported 80 episodes of haemorrhage during 5, 101 patient/month of treatment of 195 patients and of these episodes 16 were serious. Hazard et al (1967) reported ten cases of intracranial haemorrhage during a two and a half year pertiod. iSeventy-six haemorrhagic episodes were reported duning the treatment of 507 patients during a five year period (Serradiim'igni, 1969) while Straub (1970) recorded 13 deaths from haemorrhage in 70 patients treated with anticoagulant therapy. Bleeding was detected during 263 (6.8%) out of 3,862 courses of anticoagulant therapy with an identifiable lesion responsible for bleeding in half of these and death attributed to haemorrhage occurred in four cases (Coon et al, 1974) .
Inadequate attention has been paid to the mechanisms of haemorrhage in patients receiving anticoagulant therapy. The object of this prospective study was to determine the cause of haemorrhage In each case and outline ways in which this potentially serious complication of this frequently used treatment could be prevented.
METHOD
Patients receiving anticoagulant therapy were studied over a two year period.
They were receiving heparin and/or warfarin or phenindione. Anticoagulant dosage was controlled by means of the plasma activated partial thromboplastin time (APTT) in preference to the prothrombin ratio (PR) since the APTT can be used to control both heparin and oral anticoagulant dosage (Eastham, 1968 (Eastham, 1972) . Although the majority of these episodes were mild (bruising and macroscopic haematuria), such bleeding is potentially very dangerous. Of the present 50 bleeds investigated 33 were probably avoidable. In a previous study (1967?1971) it had been found that nearly one third of the episodes occurred during the first month and 46% occurred during the first two months of treatment (Eastham, 1972) .
A similar incidence is found in the present series in the same hospital group during the following two years, 36% occurring within the first month and 50% within the first three months. These results are better than in another series reported by Fuller (1959) in which 105 patients out of a group of 217 patients suffered 194 bleeding episodes, of which 24 were described as severe and in which 69 bleeds occurred in 55 of the patients during the first three months of anticoagulant therapy. (Coon et al, 1974) . In this present series only two patients bled from a known lesion, one from a duodenal ulcer and the other from a sinus related to the urinary tract. The same authors (Coon et al, 1974) considered that the risk increased after middle age and in this present study 22 (44%) of the patients who bled were over 60 years.
Although the prothrombin ratio lis estimated on all blood samples taken for anticoagulant control, the activated partial thromboplastin time is used in addition for controlling the dosage of warfarin or phenindione, since 'it has been shown to provide a more reliable warning of the likelihood of haemorrhagic accidents (Eastham, 1968) . The APTT >is also used to control the intravenous infusion of heparin and should be measured daily for this purpose. The clotting time performed by junior hospital doctors at the patient's bedside is less accurate. The present study confirms the relative safety of heparin anticoagulation, which is used frequently for prophylaxis against thromboembolism following myocardial infarction and lin the treatment of deep vein thrombosis and pulmonary embolism. In this context, however, it is worth noting that after venous thrombosis or trauma the APTT tends to be at the lower end of the normal range, or below it (Eastham and Morgan, 1964) and this is reflected in some resistance to the action of heparin. This resistance decreases with recovery, so that the daily requirement of heparin falls. It is therefore important that daily APTT estimations should be carried out so that the rate of heparin infusion can be adjusted to prevent either under treatment with the liisk of further thrombosis or overtreatment with the risk of bleeding (Eastham, Perham and Pocock, 1972) . Two patients in this series suffered haemorrhage as a result of this mechanism.
In eight cases the APTT exceeded the therapeutic range, while in three cases the APTT was within the normal range at the time of haemorrhage, with the PR within the therapeutic irange. This gives some support for the original suggestion that the APTT is more useful for the control of oral anticoagulant therapy than the PR (Eastham, 1968 
